Peer Review History
| Original SubmissionNovember 25, 2020 |
|---|
|
PONE-D-20-37165 An acute dose of intranasal oxytocin rapidly increases maternal communication and maintains maternal care in primiparous postpartum California mice PLOS ONE Dear Dr. Guoynes, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Thank you for submitting this intriguing study to Plos One. Three experts in the field have reviewed the manuscript, and all expressed considerable enthusiasm for the studies and conclusions. All three have provided helpful suggestions on how the work may be improved. Please consider whether other statistical models may be used, in particular using the litter as the statistical unit. Some more details in the introduction, as commented on by all reviewers, might be helpful. Please provide additional justification for only considering vocalizations in the ultrasonic range. The comment from Reviewer 2 about intranasal administration of oxytocin should be addressed as this route of administration has become more widely used. Please submit your revised manuscript by Feb 14 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Cheryl S. Rosenfeld, DVM, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. To comply with PLOS ONE submissions requirements, in your Methods section, please provide additional information on the animal research and ensure you have included details on (1) methods of sacrifice, (2) methods of anesthesia and/or analgesia, and (3) efforts to alleviate suffering. 3. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: In this manuscript the authors describe the results of behavioral experiments examining the effects of intranasal oxytocin on maternal behavior and vocalizations in female California mice. Unlike other rodent species, in which the function of vocalizations are not well described, vocalizations for California mice have been well characterized in the lab and in the field. Furthermore this is one of the few papers to examine how vocalizations are used by a mother to interact with pups. The authors find that intranasal oxytocin enhance maternal vocalizations in the presence of pups but not when separated from pups. This suggests that oxytocin may enhance salience of pup interactions for a mother. Overall the manuscript is well organized. The methods were detailed and experimental procedures were justified. However there are several points that need clarified and some adjustments to statistical analyses might give the authors more power to detect differences. Overall this is a very strong contribution. Introduction The authors state that preliminary data indicate that maternal simple sweeps are primarily used in interactions with pups. This is a pretty definitive statement at this point in the manuscript and I was expecting more information about what these vocalizations are and why the authors think they are not used in other contexts. I suggest the authors consider moving some of the details of these call described in the methods to the introduction. Did the authors predict that oxytocin would affect behaviors during specific stages of the behavioral testing. Methods On line 111 the authors should revise “neuroendocrine responses” to “glucocorticoid responses”, as regulation of oxytocin and corticosterone have distinct mechanisms of regulation. On line 136, reasonable people could disagree that the intranasal administration, which involves scruffing the mouse, is less stressful than an IP or SC injection. The authors could also state that the behavioral effects of intranasal oxytocin in California mice are consistent with the outcomes of central oxytocin manipulations (Duque-Wilckens et al. 2018, 2020), which also suggests that intranasal OT accesses the brain. Line 207-208: revise to observer blind to treatment Line 264-265: the authors say the total number of vocalizations was recorded and used “for comparison”. Please me more specific. Were variables of interest normalized to this variable or was it analyzed separately? Did the total number of vocalizations differ between the two groups? The authors report several statistical tests that are at nonsignificant trend level. The authors might want to consider correcting for the False Discovery Rate instead of using Bonferroni correction since this approach protects against type I error without sacrificing as much statistical power. Results It could be useful to include the age of the pups when intranasal oxytocin/behavioral observations are performed in Figure 1. It might also be more intuitive for the authors to label the microphones for reader. Please increase the fonts of the axes and labels on all bar and scatter plots, they are hard to read. Figure 2A: significance symbols are not intuitive, even after checking the figure legend. Specifically, the * comparing the different stages of the test is confusing. The labeling looks like habituation and reunion are different but I think the authors are trying to show that separation is different from the other groups. Consider replacing with a different symbol like a dagger and additional notation to indicate which groups are different. For figure 3: I suggest the authors discuss behaviors with significant differences first (perhaps total maternal care and then individual behaviors. On line 355 the authors state that high levels of retrieval are associated with less efficient maternal care. Are studies cited conducted in the home cage or in a novel environment? Effects of oxytocin are context dependent. In virgin female California mice intranasal oxytocin is anxiogenic in a novel environment but anxiolytic in the home cage. The authors should address the role of context when interpreting these results and also the extent to which effects of oxytocin change in dams versus virgins. For scatterplots, separate regression lines for control and oxytocin groups should be plotted. In most cases these lines will overlap but they are important for the few variables where these slopes differ (eg Fig. 4C). Discussion Lines 452-453: the authors should be more precise when describing their results, as only a few key variables were affected by intranasal oxytocin. Some parts of the discussion are repetitive (pups being deaf is mentioned 2x). Also, why do the authors think that sweeps are decreased in the separation phase. Line 530: the authors should be more precise in their language. There was no increase in maternal care in the oxytocin group, only the absence of a decrease. Line 538-547: When discussing effects of oxytocin on anxiety the authors should be aware that oxytocin can have anxiogenic effects, particularly in females/women. Last line of discussion: This sentence is not in line with the conclusions the authors make earlier in the manuscript where they correctly observe that intranasal oxytocin maintains maternal behavior but does increase it relative to the habituation stage. Reviewer #2: This article examines the effects of intranasal oxytocin on maternal behaviors, including maternal vocalizations (as well as pup vocalizations), in California mice. It is a well-done study and should be of broad interest to those interested in the neurobiology of maternal behavior – including those interested in human maternal behavior. I do have a few comments below intended to help improve the paper. Introduction: Lines 46-47: This sentence is an awkward introduction to neural substrates – they don’t really “complement” vocalizations as they are also involved in generating vocalizations. Line 81: Not sure that there is actual evidence that these genotypes affect oxytocin receptor availability. I think that it is a presumed relationship. Line 89: California mice are a great model but not sure why they are “uniquely” suited. Since this is a study of maternal behavior, seems like many rodent species would be suitable. Lines 96-103: Perhaps predicted effects on pup vocalizations should also be mentioned here (later it is said that no effects were predicted, but that’s not clear here). Methods: Line 137: Is this supposed to be “CSF AND plasma concentrations of OXT”? How many pups were transferred with each mother? All of them? What was the average number of pups for females that got IN OXT vs females which got saline? Line 207: I would change this to “an observer blind to treatment condition”. Lines 250-261: The sentence regarding Bonferroni corrections is in this paragraph twice, one can be removed. Figure 2 legend, section b. “Pups” at the beginning of sentence 3 is not capitalized. Results: I think that it is excellent that the data were recorded in such a way that the temporal sequence of mother and pup calls could be synced. Unfortunately, the current analysis does not seem to take full advantage of these data. A time-series analysis, or some type of dyadic analysis, would allow the authors to dig deeper into the interactions between mothers and pups, and the effects of oxytocin on those analyses. Discussion: Lines 477-488. I’m not sure that I follow the reasoning here, at least regarding thermal challenge. Wouldn’t thermal conditions alter between separation and reunion, suggesting that USVs should alter as well? Lines 490-491. Don’t need to repeat the part about pups probably being deaf (it’s also in lines 477-479). Also, even if pups can’t hear, is it possible that the mothers’ bodies would vibrate differently depending on their types of vocalizations? This presumably could be detected by the pups. Lines 539-547. Please be specific here about what behaviors you are designating as potential “anxiety” behaviors during this test. Lines 548-549. I thought you just said above that IN OXT maintains rather than increases maternal behavior… Data Availability The authors say that all the data are available within the manuscript or supporting information…I don’t see raw data, just means and standard errors. Reviewer #3: This manuscript describes a very interesting and innovative study investigating the effects of intranasal oxytocin on mothers’ behavioral and vocal responses to their pups, as well as on the pups’ vocalizations, in the California mouse. The study was well designed, and the manuscript is clearly written, for the most part. My main comments and suggestions are as follows: Given that California mouse adults and pups produce calls in the audible spectrum, in addition to USVs, it would be helpful to include a rationale for focusing exclusively on USVs. I was surprised that number of pups per litter was not used as a covariate or, as far as I could tell, used in any other way in analyses. Isn’t this likely to be a major determinant of the number of pup vocalizations produced as well as, perhaps, the amount of maternal care performed? In the introduction, it would be helpful to provide some information on the time course by which IN OXT has been found to influence behavior in other studies. The specific time course in this study is mentioned briefly in the discussion (L533-534) but nowhere else. Minor comments: Figs. 2-5 – I found it very difficult to read the text on the y-axes. Consider putting at least part of this info (e.g., the name of the behavior) above each graph. L46-47 – The statement that “neural substrates also play an important role…” is so obvious as to be unnecessary, since virtually all mammalian behaviors require neural substrates. L51-52 – This sentence is somewhat misleading. As written, it suggests that the increase in plasma OXT was co-opted evolutionarily for facilitating maternal care. However, it was presumably the increase in central OXT, rather than in plasma OXT per se, that was co-opted. L54 – It would be more appropriate to say that estrogen levels prime the neural substrates that respond to OXT, rather than that they prime OXT itself. L61 – Add “females” after “low grooming” (and possibly after “high grooming”). L63 – Can you be more specific about the reproductive state of non-lactating females – e.g., were they virgins? L66 – Change “connect” to “connects” and “activate” to “activates” (if these words refer to dopamine neurons rather than to the AVPV). L69 – Should “efficiency” be changed to “efficacy”? Either way, I’m not convinced that this statement is supported by the findings summarized above. L71 – “their” can be deleted. L89 – Please add the Latin name (currently it’s given a little later in the manuscript). L89 – The phrase “uniquely suited” seems too strong; certainly, many other species have similarly complex vocal repertoires and could therefore be excellent model species for this sort of work. For me, it would be helpful to be consistent in referring to the pup calls that were monitored as either “pup USVs” or “pup whines” rather than using both phrases. I realize, though, that other readers might not find this lack of consistency to be a problem. L94-95 – The statement that “maternal simple sweeps and pup wines are the primary maternal USVs” is confusing, as it seems to suggest that pup whines are produced by mothers, not by pups. Remove “maternal” before “USVs”? L101-103 – To use parallel sentence structure, either remove “enhance” in L102 or add a verb before “maternal USV production”. L110 – Delete “stress” – dexamethasone isn’t a stressor! “Stress” can be replaced with “challenge,” but this isn’t necessary. L110 – Change “between” to “in” or “within”. L108-111 – It’s not clear how this statement is relevant to this paragraph. Yes, females across this age range have been shown to have similar cort responses to CRH and DEX, but that’s not necessarily applicable to “neuroendocrine responses” in general. L114 – Confusing what they were randomly assigned to. Do you mean that female and male pairmates were randomly assigned to one another or that the pairs were randomly assigned to something (presumably experimental condition)? L116 – Remove “Female”. L120 – Change “Treatments” to something like “Mothers” or “Mice” or “Subjects”. L129-130 – Was the cannula needle alternated between nostrils within individual animals or across animals? L130 – “Mice” in this line presumably refers to house mice (Mus) and not California mice. Please clarify this, as some readers won’t know that California mice aren’t “real mice” phylogenetically. L138 – Change “human” to “humans”. L143 – Delete “that”. L155 – Harris et al. 2017 isn’t in the reference list, and it’s not clear what paper is being referred to. L156-157 – The relevance of this sentence about blunted behavioral responses in parents isn’t clear. L260-261 – This sentence is identical to one earlier in the paragraph. Delete. L266-267 – I don’t understand why t-tests were used to examine main effects of treatment. Wasn’t the effect of treatment discernible from the 2-way ANOVAs, which I assume examined the effects of test phase and treatment? L346-347 – This sentence is confusing for two reasons. First, it’s not clear which test phase it refers to (I assume it’s the beginning of the reunion phase, but that should be stated explicitly). Second, the fact that it comes right after two sentences about the use of delta scores seems to suggest that this sentence, too, refers to delta scores, but that’s not the case. L355-357 – Please indicate which species this sentence refers to. L385 – The subheading sounds awkward. Consider changing to “Correlations of maternal care with maternal USVs and pup USVs”. L424-425 – The phrasing “had no effect on…” strikes me as odd, since this section talks about correlations rather than causal relationships. Change to “was not correlated with”? L438 – Omit “later in life” since this is implicit in “lifelong”? L452-453 – Not clear what “the control increase in the habituation phase” refers to. L455 – Marler & Monari 2020 is not in the reference list. L485-488 – Please specify the species being discussed. L490 – The phrase “driven by the mother” isn’t clear, because it could refer to either the mother’s vocalizations on the mother’s responses to the pups’ vocalizations. Please clarify. L504 – The phrase “sheep and ewes” is redundant. Say either “lambs and ewes” or simply “sheep”. L506 – Change “ewes” to “lambs”. L507 – I don’t understand the phrase “but using high frequency calls to during vocal exchanges.” Is “to” meant to be “too” or is there a missing word? L521 – Add a comma after the reference. L522-525 – Please specify what species are being referred to. L550-552 – If I understand this sentence correctly, it’s meant to refer to higher endogenous levels of OXT in mothers than in other females. If so, then “IN” should be removed. Fig. 3D caption – Indicate that this treatment effect was not seen in Controls, or that the net positive effect of IN OXT was significant relative to Controls? Supp. Fig. 1 – The first three definitions contain typos. Supp. Fig. 1 – It would seem that mothers often meet the criteria for “freezing” while huddling their pups. Are these two behaviors mutually exclusive? Please clarify. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-20-37165R1 An acute dose of intranasal oxytocin rapidly increases maternal communication and maintains maternal care in primiparous postpartum California mice PLOS ONE Dear Dr. Guoynes, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Thank you for submitting this revised paper. The three original reviewers were very positive about the updated work. There are a few minor corrections and clarifications suggested before it can be considered for publication. Appreciate if you could respond to these suggestions. A final decision can then be made. Please submit your revised manuscript by May 03 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Cheryl S. Rosenfeld, DVM, PhD Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: All of my comments have been addressed in the revisions. The authors did a very nice job, this is a great contribution. Reviewer #2: (No Response) Reviewer #3: The authors were responsive to my previous comments, and the manuscript has improved. However, I have quite a few additional suggestions for increasing the clarify of the writing. L12 – Mention saline controls. L19 - Not clear what “Maternal-pup USVs were correlated upon reunion” means – the number of USVs? Frequency? Timing? (Also, “Maternal-pup USVs” itself isn’t clear; try using something like “Mothers’ and pups’ USVs” instead.) L20 – “more positive change” is confusing. Change to something like “larger increase”? L24 – Change “single dose of” to “single treatment with”? L32 – Explain “pup whines.” L46-48 – It’s somewhat misleading to say that OXT “likely plays an important role in… producing behaviors that support maternal care,” since we already know this statement to be true (as summarized in the following sentences.” L56-58 – The point about “many species” doesn’t follow from the previous sentences, which mention only rats and mice. L63 – As I mentioned in my previous review, I find the phrase “both non-lactating and lactating maternally-experienced females” confusing because it can be interpreted to mean that only the lactating females were maternally experienced. Maybe try rephrasing as “maternally experienced females that were either lactating or non-lactating”. L68-69 – This sentence is very similar to the one at the end of the previous paragraph, which raises the question of why these two paragraphs are separate. Also, the first sentence of this paragraph (L59-60) seems to imply that the paragraph will focus on OXT receptors, which isn’t true of the second half of the paragraph. Consider removing the two sentences on receptors, since you didn’t quantify receptors in this study, and either reorganizing or consolidating the remainder of this paragraph and the previous paragraph. L84 – Consider starting a new paragraph with the sentence beginning “A key social behavior…” Also, you might want to add something like “in the context of OXT” after “not been measured”. L98 – Pultorak et al. 2017 is cited twice. L104 – Change “have” to either “can have” or “has.” L120 – Maybe change “responses” to “responsiveness” to make the statement a little broader? As is, it seems to refer only to the CRH and DEX challenges mentioned earlier in the same sentence. L120-121 – The description of pair housing/family composition is out of order, since you don’t mention the actual pairing of animals until after the next sentence. L124 – Again, it’s a little confusing to mention that pairs produced offspring before talking about when females were visibly pregnant (subsequent sentence). L150 – Has IN treatment been shown to be less stressful than ICV treatment? If not, please indicate that this is presumed to be the case, rather than stating it as a fact. L224 – The first part of this sentence is confusing. Do you mean that the videos were scored in random order (rather than the behaviors themselves)? L294-297 – This seems backward. If scores from the reunion phase were subtracted from scores from the habituation phase, then positive difference scores indicate that habituation-phase scores were higher than reunion-phase scores. L340-341 – The point about “both consistency and differences” is confusing, and the sentence overall isn’t particularly informative. I suggest that you delete it. L347 – It’s not essential, but I think it would be helpful to specify that you’re referring to the number of maternal and pup calls (rather than some other measure). The same point applies to several other parts of the manuscript, including L408-411 and L440-441. L396-403 – The first sentence of this paragraph indicates that the following analyses focus on effects of IN OXT, but the next two sentences sound like they’re describing within-subjects changes (or lack thereof) over time rather than effects of IN OXT. Please clarify. L474 – As described in the methods, mothers had “multisensory pup experience,” although without touch, during the separation phase. Therefore, it would be more appropriate to emphasize the presence or absence of tactile stimuli in this sentence, rather than including this point only parenthetically. Same point for L480. L477 – Delete “in” and “be.” L561-563 – Which species do these references refer to? ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
An acute dose of intranasal oxytocin rapidly increases maternal communication and maintains maternal care in primiparous postpartum California mice PONE-D-20-37165R2 Dear Dr. Guoynes, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Cheryl S. Rosenfeld, DVM, PhD Section Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-20-37165R2 An acute dose of intranasal oxytocin rapidly increases maternal communication and maintains maternal care in primiparous postpartum California mice Dear Dr. Guoynes: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Cheryl S. Rosenfeld Section Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .